News Release Immediate Release Semi-Finalists Chosen for BioInnovation Challenge Halifax, NS – August 29, 2016 The semi-finalists have been chosen for the 2016 edition of The BioInnovation Challenge (BIC). Scott Moffitt, Managing Director of BioNova, the host of BIC, announced today that a selection committee has chosen the semi-finalists who will take part in the…

See original news release here  Halifax, Nova Scotia; August 25, 2016 – Immunovaccine Inc. (TSX: IMV; OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announced new data from its Phase 1/1b trial in ovarian cancer, which reinforced previously reported results showing that DPX-Survivac was well tolerated, with no unexpected treatment-related serious adverse events…

2015 © Copyright - Bionova